£55.55

Colorectal Cancer: Prevention, Diagnosis and Treatment

Price data checked 1 day ago

View at Amazon

Price History & Forecast

Last 90 days • 90 data points

Historical
Generating forecast...
£55.55 £54.66 £54.85 £55.05 £55.24 £55.44 £55.63 11 February 2026 05 March 2026 27 March 2026 18 April 2026 11 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
85 days 5 days · current 0 21 43 64 85 £55 £56 Days at Price

Price Analysis

Most common price: £55 (85 days, 94.4%)

Price range: £55 - £56

Price levels: 2 different prices over 90 days

Description

Product Description Adenocarcinoma is the predominant malignancy found in the colon and rectum. Colorectal cancer is the third most common cancer diagnosed in the developed world with a high incidence of mortality and morbidity. The average five-year survival rate remains poor at 55%, although the development of new drugs has improved the survival rate of colorectal cancer patients. The prognosis of colorectal cancer remains poor in spite of the development of novel therapeutic strategies. Human colorectal cancer represents a heterogeneous group of diseases, and its molecular classification is increasingly important. Characterization of novel biomarker targets may lead to prolong the survival rate of colorectal cancer. Biomarkers may have a potential role in screening, diagnosis, prognosis and monitoring disease. Mutations in the KRAS gene in ~40% of tumors have been reported to be induced by genetic and epigenetic alterations. This book, comprised of four chapters, introduces recent topics regarding colorectal cancer, and provides recent highlighted information concerning prevention, diagnosis and treatment. This book will be of interest to undergraduate and graduate students, biomedical researchers, and medical doctors focused on the fields of molecular and cellular biology, medical sciences, and clinical challenges. About the Author Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
20 December 2019
Listed Since
12 September 2019

Barcode

No barcode data available

Similar Products You Might Like

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
82% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 04 May 2026
Gene Regulation and Therapeutics for Cancer
81% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 11 May 2026
Management of Colorectal Cancers in Older People
81% match

Management of Colorectal Cancers in Older People

Springer

£80.64 11 May 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
81% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£40.30 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
79% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Cell Signaling & Molecular Targets in Cancer
78% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Nu-Oncology; Cancer Prevention and Anti-Aging: Volume 1
78% match

Nu-Oncology; Cancer Prevention and Anti-Aging: Volume 1

£46.02 11 May 2026
Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)
77% match

Signal Transduction in Cancer Metastasis: 15 (Cancer Metastasis - Biology and Treatment, 15)

Springer

£113.77 11 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
77% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
77% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 11 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
77% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 11 May 2026
Oral Cancer: Diagnosis and Therapy
77% match

Oral Cancer: Diagnosis and Therapy

Springer

£94.43 11 May 2026
Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)
77% match

Lymphangiogenesis in Cancer Metastasis: 13 (Cancer Metastasis - Biology and Treatment, 13)

Springer

£113.76 11 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
77% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Superficial Esophageal Neoplasm: Pathology, Diagnosis, and Therapy
77% match

Superficial Esophageal Neoplasm: Pathology, Diagnosis, and Therapy

Springer

£113.76 11 May 2026
Cell Signaling & Molecular Targets in Cancer
76% match

Cell Signaling & Molecular Targets in Cancer

Springer

£43.99 04 May 2026
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology
76% match

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology

Springer

£107.98 11 May 2026
Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)
76% match

Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series)

Springer

£66.52 11 May 2026
Precision Medicine in Oncology
76% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
DNA Repair of Cancer Stem Cells
76% match

DNA Repair of Cancer Stem Cells

Springer

£108.75 11 May 2026
DNA Methylation, Epigenetics and Metastasis: 7 (Cancer Metastasis - Biology and Treatment, 7)
76% match

DNA Methylation, Epigenetics and Metastasis: 7 (Cancer Metastasis - Biology and Treatment, 7)

Springer

£149.38 11 May 2026
Food Factors for Cancer Prevention
76% match

Food Factors for Cancer Prevention

Springer

£78.84 11 May 2026
76% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 11 May 2026
Hormone Therapy and Castration Resistance of Prostate Cancer
76% match

Hormone Therapy and Castration Resistance of Prostate Cancer

Springer

£109.24 04 May 2026